GR860117B - Pyridopyrimidine methods for their preparations and their use as medicaments - Google Patents

Pyridopyrimidine methods for their preparations and their use as medicaments

Info

Publication number
GR860117B
GR860117B GR860117A GR860100117A GR860117B GR 860117 B GR860117 B GR 860117B GR 860117 A GR860117 A GR 860117A GR 860100117 A GR860100117 A GR 860100117A GR 860117 B GR860117 B GR 860117B
Authority
GR
Greece
Prior art keywords
pyridopyrimidine
medicaments
preparations
methods
pyridopyrimidines
Prior art date
Application number
GR860117A
Other languages
English (en)
Inventor
Meyer Dr Horst
Wehinger Dr Egbert
Garthoff Dr Bernward
Kazda Dr Stanislav
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR860117B publication Critical patent/GR860117B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
GR860117A 1985-01-19 1986-01-17 Pyridopyrimidine methods for their preparations and their use as medicaments GR860117B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853501696 DE3501696A1 (de) 1985-01-19 1985-01-19 Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
GR860117B true GR860117B (en) 1986-05-16

Family

ID=6260235

Family Applications (1)

Application Number Title Priority Date Filing Date
GR860117A GR860117B (en) 1985-01-19 1986-01-17 Pyridopyrimidine methods for their preparations and their use as medicaments

Country Status (18)

Country Link
US (1) US4621082A (el)
EP (1) EP0189045B1 (el)
JP (1) JPS61167688A (el)
CN (1) CN1010947B (el)
AT (1) ATE50407T1 (el)
AU (1) AU578783B2 (el)
CA (1) CA1276636C (el)
DE (2) DE3501696A1 (el)
DK (1) DK23386A (el)
ES (1) ES8704491A1 (el)
FI (1) FI81574C (el)
GR (1) GR860117B (el)
HU (1) HU195812B (el)
NO (1) NO164353C (el)
NZ (1) NZ214842A (el)
PH (1) PH22610A (el)
PT (1) PT81860B (el)
ZA (1) ZA86363B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278686A1 (en) * 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
JPH04260503A (ja) * 1991-02-13 1992-09-16 Sekisui Jushi Co Ltd ピッキングシステム
JP3013905B2 (ja) * 1991-06-28 2000-02-28 花王株式会社 自動倉庫の入出庫方法
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US6756367B2 (en) 1998-02-03 2004-06-29 Novartis Ag Benzo-oxadiazoles, -thiadiazoles and -1,4-diazines, pharmaceutical compositions containing them and a process for preparing them
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP2006515847A (ja) * 2002-12-13 2006-06-08 ニューロジェン・コーポレーション カプサイシン受容体調節剤としてのカルボン酸、ホスフェート又はホスホネート置換キナゾリン−4−イルアミン類縁体
US20070082920A1 (en) * 2005-10-06 2007-04-12 Yongsheng Song NAD+-dependent DNA ligase inhibitors
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
CN107405350A (zh) * 2016-02-04 2017-11-28 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021332A (en) * 1954-01-04 1962-02-13 Burroughs Wellcome Co Pyrido (2, 3-d) pyrimidine compounds and method of making
GB1129084A (en) * 1965-02-18 1968-10-02 Wellcome Found Novel pyrido[2,3-d]pyrimidines
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3438351A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
JPS61167688A (ja) 1986-07-29
ZA86363B (en) 1986-09-24
EP0189045B1 (de) 1990-02-14
DK23386D0 (da) 1986-01-17
EP0189045A3 (en) 1988-10-05
HU195812B (en) 1988-07-28
EP0189045A2 (de) 1986-07-30
ES8704491A1 (es) 1987-04-01
ES551013A0 (es) 1987-04-01
NO164353B (no) 1990-06-18
HUT40127A (en) 1986-11-28
DE3669041D1 (de) 1990-03-22
DK23386A (da) 1986-07-20
US4621082A (en) 1986-11-04
FI81574C (fi) 1990-11-12
AU578783B2 (en) 1988-11-03
PT81860B (pt) 1988-05-27
ATE50407T1 (de) 1990-02-15
NO855342L (no) 1986-07-21
NZ214842A (en) 1988-07-28
CA1276636C (en) 1990-11-20
NO164353C (no) 1990-09-26
PH22610A (en) 1988-10-17
FI81574B (fi) 1990-07-31
AU5219386A (en) 1986-07-24
FI860197A (fi) 1986-07-20
CN86100279A (zh) 1986-11-19
CN1010947B (zh) 1990-12-26
PT81860A (en) 1986-02-01
DE3501696A1 (de) 1986-07-24
FI860197A0 (fi) 1986-01-16

Similar Documents

Publication Publication Date Title
EP0196038A3 (en) Azolyl methyl oxiranes, their preparation and use as plant-protecting agents
NO861956L (no) Fremgangsmaate for fremstilling av askorbinsyrederivater.
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
GR860117B (en) Pyridopyrimidine methods for their preparations and their use as medicaments
IT8324207A0 (it) Carbossamido-derivati di 1,2,4-tiadiazolo [3,2-a] pirimidine e procedimento per la loro preparazione
KR880701719A (ko) 아자인돌 및 인돌리진 유도체, 이들의 제조방법 및 이들 약제로서의 용도
PT86298A (en) Method for the treatment of an aqueous medium with copolymers containing acrylamidoalkane sulfonic acid
NO870126D0 (no) 7-(azabicykloalkyl)-chinolinkarboksylsyre- og naftyri-donkarboksylsyre-derivater.
PH24769A (en) 2,6-dichloro-5-fluoro-pyridine-3-carboxylic acid derivatives
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
IT8519770A0 (it) Procedimento per la preparazione di 2-alchil ciclopent-2-enoni.!
NZ193579A (en) 2-trans-(2-arylethen-1-yl)-4-oxo-4h-pyrido (1,2-a)-pyrimid-7-ylcarboxylic acid derivatives
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
ES482280A1 (es) Un procedimiento para la preparacion de nuevos derivados 2- (1h-imidazol-1-il)etoxi de pirazolo-3,4-b-piridina-5-metano-les.
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
DK204780A (da) 3-substituerede hexahydropyrimido (1,2-a) azepiner eller salte deraf deres fremstilling og anvendelse
FI863404A (fi) Kardiotoniska fosfodiesterasinhibitorer i komplex med vattenloesliga vitaminer.
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
ES548648A0 (es) Procedimiento de preparacion de derivados de 1-oxa-2-oxo-3, 8-diaza-spiro (4,5)-decano
PT87077A (pt) Terc-butylamino-3-(phenyl-2:-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
MX9203195A (es) Derivados de oxadiazol alquil purina utiles como agentes antitusivos.